Carisoprodol, Aspirin and Codeine Phosphate
- Product NDC
- 0185-0749
- 11-digit product format
- 001850749
- Labeler code
- 0185
- Product ID
- 0185-0749_e1eaeba6-7e4b-4851-9554-8564fc7c4c72
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Carisoprodol, Aspirin and Codeine Phosphate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Eon Labs, Inc.
- Application
- ANDA040118
- Marketing category
- ANDA
- Marketing start
- 1996-04-16
- Marketing end
- 2019-09-30
- Substance
- CARISOPRODOL; ASPIRIN; CODEINE PHOSPHATE
- Active strength
- 200 mg/1; mg/1; mg/1
- Pharmacologic classes
- Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Full Opioid Agonists [MoA],Opioid Agonist [EPC]
- DEA schedule
- CIII
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record